020 — Ryzumvi Mydriasis Reversal Drops, Exxua for MDD, Likmez Metronidazole Liquid Formulation, DNA Test for Hereditary Cancers, Tofidence Actemra Biosimilar, Pompe Disease Combination Therapy, Subcutaneous Entyvio, NurOwn in ALS

Here is information on the latest US FDA approvals, the week of September 25 –  September 29, 2023Ryzumvi (Phentolamine Ophthalmic Solution) for Dilated PupilsThe FDA has approved Ryzumvi (phentolamine ophthalmic…

Continue Reading020 — Ryzumvi Mydriasis Reversal Drops, Exxua for MDD, Likmez Metronidazole Liquid Formulation, DNA Test for Hereditary Cancers, Tofidence Actemra Biosimilar, Pompe Disease Combination Therapy, Subcutaneous Entyvio, NurOwn in ALS

018 — Ojjaara for Anemia in Myelofibrosis, Resmetirom for NASH, COVID-19 Vaccine Update, Phenylephrine, Patisiran in ATTR-CM

Here is information on the latest US FDA approvals, the week of September 11 –  September 15, 2023.FDA Approves Ojjaara (Momelotinib) for Anemia in MyelofibrosisThe FDA has approved Ojjaara (momelotinib)…

Continue Reading018 — Ojjaara for Anemia in Myelofibrosis, Resmetirom for NASH, COVID-19 Vaccine Update, Phenylephrine, Patisiran in ATTR-CM

002 — BionicPancreas, Vyjuvek, Epkinly, Miebo, KryptorTest, Rinvoq, RSVpreF, BCI

Here is information on the latest US FDA approvals, the week of May 15- May 19, 2023. Please subscribe, rate and review. Thank you!iLet Bionic PancreasThe FDA has approved components…

Continue Reading002 — BionicPancreas, Vyjuvek, Epkinly, Miebo, KryptorTest, Rinvoq, RSVpreF, BCI